Cancer & Blood Disorders Center Banner

Tumor Board Conference Series

When

Wednesdays, 7:15 am to 8:15 am EST

Tumor Board: 1st & 3rd Wednesday
Neuro-Oncology: 2nd Wednesday
Leukemia & BMT: 4th Wednesday, odd-numbered months
Cellular Therapy: 4th Wednesday, even-numbered months

Where

Online: Virtual Meeting via Microsoft Teams.

Join the mailing list

Contact Olivia.Hoo@Nicklaushealth.org to be added to the distribution List.

Upcoming Events

November 2024

Title Date
Tumor Board Session - 11/06/2024 11/06/2024 - 7:15am to 8:15am
Neuro-Oncology Conference Session - 11/13/2024 11/13/2024 - 7:15am to 8:15am
Tumor Board Session - 11/20/2024 11/20/2024 - 7:15am to 8:15am
Leukemia & BMT Conference Session - 11/27/2024 11/27/2024 - 7:15am to 8:15am

Series Details

Course Faculty

Course Chair & Moderator:

Dr. Ziad Khatib
Vice President of the Medical Staff
Pediatric Hematology-Oncology,
Nicklaus Children's Hospital

Committee Members/Moderators:

Dr. Haneen Abdella
Survivorship Program,
Pediatric Hematologist/Oncology,
Kidz Medical Services

Dr. Guillermo De Angulo
Pediatric Hematology-Oncology,
Kidz Medical Services

Dr. Jorge Ricardo Galvez Silva
Medical Director,
Bone Marrow Transplant Program,
Pediatric Hematology-Oncology,
Kidz Medical Services

Dr. Maggie Fader
Sarcoma & Solid Tumors Program,
Pediatric Hematologist/Oncology,
Kidz Medical Services

Dr. Ossama Maher
Co-Director, Blood and Marrow Transplant Program
Pediatric Neuro-Oncology,
Kidz Medical Services

 

Series Coordinators:

Olivia Hoo
Secretary, Cancer and Blood Disorders Institute

Estivaly Rodriguez
Manager, Quality Program, Cancer and Blood Disorders Institute

Angela Quintana
Admin. Assistant, Blood and Marrow Transplant Program

Cristian Aleman
BMT Administrative Assistant, Blood and Marrow Transplant Program

Target Audience

This activity is intended for pediatricians, pediatric subspecialists, pediatric radiotherapists, Fellows, Residents and Medical students and other child health care professionals interested in the latest developments in Pediatric Oncology

Accreditation

Accreditation Statement: Nicklaus Children’s Hospital is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Faculty/Planner Disclosure Policy: In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all planners, teachers, and authors involved in the development of CME content are required to disclose to the accredited provider their financial relationships. Relevant financial relationships will be disclosed to the activity audience. All relevant conflicts of interest disclosed have been mitigated before the start of the session.

Commercial Support Disclosure: No commercial support was received for this activity.

Session Credit Designation Statement(s):

AMA: Nicklaus Children’s Hospital has approved and designated this live activity for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Attendance/CE: This is an accredited educational activity. Non-Physician participants who complete the activity requirements will receive a certificate of completion commensurate with their time participating in this course approved for AMA PRA Category 1 CreditsTM.

Credit Reporting

Badge: Learner must Self-Report

All licensees must self-report to CE Broker: Credits earned for this activity must be self-reported to your accrediting agency. For more information visit our Credit Processing page for CE Broker Reporting Details.

View all Sessions

Session
Cellular Therapy Educational Session - 12/25/2024
Tumor Board Session - 12/18/2024
Neuro-Oncology Conference Session - 12/11/2024
Tumor Board Session - 12/04/2024
Leukemia & BMT Conference Session - 11/27/2024
Tumor Board Session - 11/20/2024
Neuro-Oncology Conference Session - 11/13/2024
Tumor Board Session - 11/06/2024
Cellular Therapy Educational Session - 10/23/2024 "BMT Antimicrobial Prophylaxis Guidelines"
Tumor Board Session - 10/16/2024
Neuro-Oncology Conference Session - 10/09/2024
Tumor Board Session - 10/02/2024
Leukemia & BMT Conference Session - 09/25/2024
Tumor Board Session - 09/18/2024
Neuro-Oncology Conference Session - 09/11/2024
Tumor Board Session - 09/04/2024
Cellular Therapy Educational Session - 08/28/2024 "Update on the Role of CART-T Cells for Treatment of Acute Lymphoblastic Leukemia: Pros and Cons"
Tumor Board Session - 08/21/2024
Neuro-Oncology Conference Session - 08/14/2024
Tumor Board Session - 08/07/2024
Leukemia & BMT Conference Session - 07/24/2024
Tumor Board Session - 07/17/2024
Neuro-Oncology Conference Session - 07/10/2024
Tumor Board Session - 07/03/2024
Tumor Board Session - 06/19/2024
Neuro-Oncology Conference Session - 06/12/2024
Tumor Board Session - 06/05/2024
Leukemia & BMT Conference Session - 05/22/2024
Tumor Board Session - 05/15/2024
Neuro-Oncology Conference Session - 05/08/2024
Tumor Board Session - 05/01/2024
Cellular Therapy Educational Session - 04/24/2024 - Current Sate in GVHD Therapy
Tumor Board Session - 04/17/2024
Neuro-Oncology Conference Session - 04/10/2024
Tumor Board Session - 04/03/2024
Leukemia & BMT Conference Session - 03/27/2024
Tumor Board Session - 03/20/2024
Neuro-Oncology Conference Session - 03/13/2024
Tumor Board Session - 03/06/2024
Cellular Therapy Educational Session - 02/28/2024 - Infant Medulloblastoma
Tumor Board Session - 02/21/2024
Neuro-Oncology Conference Session - 02/14/2024
Tumor Board Session - 02/07/2024
Leukemia & BMT Conference Session - 01/31/2024
Tumor Board Session - 01/17/2024
Neuro-Oncology Conference Session - 01/10/2024
Tumor Board Session - 01/03/2024